| |
| |
|
| Insider
Information: |
Adams Adrian |
| Relationship: |
COB, CEO and President... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
6,898,466 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$201,827 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,898,466 |
|
|
| Total
Value |
$201,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.0
|
| Percentage
Gain/Loss : |
 3.6%
|
39.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
Director |
2023-10-10 |
11,168 |
2013-05-24 |
0 |
Premium* |
|
|
POZEN Inc |
POZN |
Chief Executive Office... |
2015-11-12 |
2,944,888 |
2015-06-03 |
0 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Chief Executive Office... |
2017-05-11 |
3,787,610 |
2016-02-05 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2023-06-06 |
134,800 |
2019-06-06 |
0 |
Premium* |
|
|
Impel Neuropharma Inc |
IMPL |
COB, CEO and President... |
2021-08-18 |
20,000 |
2021-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
581 |
11,168 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
134,800 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
211,750 |
0 |
- |
|
| IMPL |
Impel Neuropharma Inc |
COB, CEO and President |
• • – |
2021-08-18 |
4 |
B |
$13.81 |
$279,790 |
D/D |
20,000 |
20,000 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
196,250 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
91,100 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
186,250 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2020-06-15 |
4/A |
B |
$1.29 |
$128,900 |
D/D |
100,000 |
178,750 |
2.39 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2020-06-15 |
4 |
S |
$1.29 |
$128,900 |
D/D |
(100,000) |
178,750 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
77,400 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2019-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
78,750 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
13,700 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
218,380 |
3,787,610 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-15 |
4 |
B |
$2.46 |
$1,230,950 |
D/D |
500,000 |
3,569,230 |
2.81 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
124,342 |
3,069,230 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,944,888 |
2,944,888 |
0 |
- |
|
| POZN |
POZEN Inc |
Chief Executive Officer |
• • – |
2015-11-12 |
4 |
B |
$6.68 |
$2,995,815 |
D/D |
448,529 |
2,944,888 |
2.81 |
- |
|
| POZN |
POZEN Inc |
Chief Executive Officer |
• • – |
2015-11-11 |
4 |
B |
$6.45 |
$3,556,712 |
D/D |
551,471 |
2,496,359 |
2.81 |
- |
|
| POZN |
POZEN Inc |
Chief Executive Officer |
• • – |
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,944,888 |
1,944,888 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2013-05-28 |
4 |
B |
$8.39 |
$419,500 |
D/D |
50,000 |
75,000 |
2.39 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2013-05-24 |
4 |
B |
$7.78 |
$194,500 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2012-08-08 |
4 |
D |
$31.00 |
$651,000 |
D/D |
(21,000) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2011-08-15 |
4 |
A |
$10.71 |
$161,095 |
D/D |
15,000 |
18,000 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2011-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
